Study Title
SAXON-PC: A Phase II Randomized Trial of Stereotactic Body Radiation Therapy (SBRT) And Radium (Ra-223) Dichloride for Oligorecurrent, Non-castrate Resistant Prostate Cancer
Study Details
Description:
Participants will either receive treatment with standard SBRT and the study drug Radium (Ra-223) dichloride, or standard SBRT alone.
Sponsor:
Memorial Sloan Kettering Cancer Center
Government Study Link:
NCT05133440 - Click here to see study onClinicalTrials.gov